Lexaria Bioscience Corp (LEXX)
3.09
+0.63
(+25.61%)
USD |
NASDAQ |
Apr 30, 16:00
3.11
+0.02
(+0.65%)
After-Hours: 20:00
Lexaria Bioscience Cash and Short Term Investments (Quarterly): 4.793M for Feb. 29, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 4.793M |
| November 30, 2023 | 2.027M |
| August 31, 2023 | 1.478M |
| May 31, 2023 | 3.434M |
| February 28, 2023 | 3.540M |
| November 30, 2022 | 4.803M |
| August 31, 2022 | 6.161M |
| May 31, 2022 | 7.339M |
| February 28, 2022 | 8.912M |
| November 30, 2021 | 10.18M |
| August 31, 2021 | 11.75M |
| May 31, 2021 | 8.509M |
| February 28, 2021 | 9.818M |
| November 30, 2020 | 0.5691M |
| August 31, 2020 | 1.313M |
| May 31, 2020 | 2.052M |
| February 29, 2020 | 0.7636M |
| November 30, 2019 | 1.356M |
| August 31, 2019 | 1.349M |
| May 31, 2019 | 2.071M |
| February 28, 2019 | 3.164M |
| November 30, 2018 | 2.716M |
| August 31, 2018 | 1.737M |
| May 31, 2018 | 2.081M |
| February 28, 2018 | 2.318M |
| Date | Value |
|---|---|
| November 30, 2017 | 2.210M |
| August 31, 2017 | 2.533M |
| May 31, 2017 | 2.789M |
| February 28, 2017 | 0.5236M |
| November 30, 2016 | 0.1242M |
| August 31, 2016 | 0.0934M |
| May 31, 2016 | 0.0371M |
| February 29, 2016 | 0.0402M |
| November 30, 2015 | 0.084M |
| August 31, 2015 | 0.2601M |
| May 31, 2015 | 0.8321M |
| February 28, 2015 | 0.792M |
| November 30, 2014 | 0.4311M |
| July 31, 2014 | 0.5785M |
| April 30, 2014 | 0.9517M |
| January 31, 2014 | 0.0287M |
| October 31, 2013 | 0.0655M |
| July 31, 2013 | 0.0275M |
| April 30, 2013 | 0.0445M |
| January 31, 2013 | 0.0389M |
| October 31, 2012 | 0.1805M |
| July 31, 2012 | 0.0164M |
| April 30, 2012 | 0.1206M |
| January 31, 2012 | 0.1405M |
| October 31, 2011 | 0.0312M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.5691M
Minimum
Nov 2020
11.75M
Maximum
Aug 2021
4.611M
Average
3.487M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 350.49M |
| Sunshine Biopharma Inc | 16.29M |
| Acasti Pharma Inc | 25.11M |
| Edesa Biotech Inc | 4.268M |
| Xenon Pharmaceuticals Inc | 638.08M |